According to a media release issued on March 18 by EDAP TMS, the US healthcare insurance firm CIGNA has agreed to cover the use of high-intensity focal ultrasound (HIFU) as a second-line, salvage therapy for men with radiorecurrent prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: focused, HIFU, high-intensity, insurance, salvage, Treatment, ultrasound | Leave a comment »
An article originally published in Prostate Cancer and Prostatic Diseases, earlier this year, predicts that expansion of insurance coverage here in the USA will have major impact on prostate cancer outcomes in the relatively near future. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: coverage, Diagnosis, insurance, outcome, Treatment | Leave a comment »
A recently published paper in the journal Urologic Oncology has confirmed that (regrettably but unsurprisingly), here in the USA, African-American men with high-risk prostate cancer are significantly less likely than white males to be given definitive treatment with curative intent. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: African American, insurance, risk, Treatment | Leave a comment »
Many readers of this blog quite certainly have strong opinions about the position of the American Cancer Society (ACS) on use of the PSA test in assessment of risk for prostate cancer. However, one does have to give credit where credit is due on a related matter. … READ MORE …
Filed under: Uncategorized | Tagged: insurance, PSA, screening, testing | 7 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 